Advertiser / Brand
Colgate-Palmolive vs Kimberly-Clark
Structured technology and market comparison · 2026
Direct Feature Comparison
Colgate-Palmolive · vs · Kimberly-ClarkConsumer goods company selling household and personal care brands.
Consumer goods manufacturer focused on tissue, hygiene and personal care.
Analyze all overlapping signals and tech stacks for Colgate-Palmolive and Kimberly-Clark
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Colgate-Palmolive and Kimberly-Clark?
When comparing Colgate-Palmolive and Kimberly-Clark, both platforms operate within the Advertiser / Brand ecosystem. Colgate-Palmolive is positioned as Consumer goods company selling household and personal care brands, whereas Kimberly-Clark focuses on Consumer goods manufacturer focused on tissue, hygiene and personal care. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Colgate-Palmolive and Kimberly-Clark?
When evaluating Colgate-Palmolive and Kimberly-Clark, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Colgate-Palmolive and Kimberly-Clark compare?
Colgate-Palmolive is headquartered in United States (founded in 1806) with >5,000 employees. Kimberly-Clark is based in United States (founded in 1872) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Colgate-Palmolive vs Kimberly-Clark
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Colgate-Palmolive
Recent Signals
- ·AdweekExperiential Marketing
Bravo Fan Fest Brands Blend with Fan Experiences
Bravo Fan Fest 2026 in Charleston, SC featured five brand sponsors—Colgate Optic White, Planet Fitness, State Farm, Wayfair, and Wendy's—each creating activations that integrated with the show's fandom. The event, smaller than BravoCon, emphasized intimate and community-driven engagement. Brandon activations included interactive games, photo ops, co-branded merchandise, and exclusive offers tied to Bravo shows, such as Wendy's new Frosty flavors named after Real Housewives stars. Executives from NBCUniversal highlighted the strategy of leveraging fan passion to drive brand demand, describing it as a 'flywheel' effect.
- Bravo Fan Fest returned to Charleston, SC on October 24, 2026 after debuting in Miami in 2024.
- Five brand sponsors participated: Colgate Optic White, Planet Fitness, State Farm, Wayfair, and Wendy's.
- Wendy's debuted two new Frosty flavors inspired by Real Housewives stars Alicia Carmody and Lisa Barlow.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for Colgate-Palmolive (2026-10-30)
Colgate-Palmolive reported solid Q3 2026 financial results, with net sales increasing 4.6% year-over-year to $5,369 million, driven by 1.7% volume growth, 2.0% pricing gains, and a 1.0% foreign exchange tailwind. Organic sales grew 3.6%, bolstered by strength in Latin America (+6.0%) and Hill's Pet Nutrition (+5.7%), offsetting a 1.6% organic sales decline in North America. Operating profit rose 2.7% to $1,088 million, while diluted EPS increased to $0.94 ($0.97 non-GAAP), supported by gross margin expansion of 80 bps to 60.2% through funding-the-growth cost savings. Operating performance absorbed $30 million of pre-tax restructuring charges in Q3 ($333 million year-to-date) associated with the Strategic Growth and Productivity Program, which targets $200–$300 million in annualized pre-tax savings by 2028. Free cash flow generation remained strong, with nine-month operating cash flows increasing 6.1% to $2,913 million. Despite continued raw material inflation and macroeconomic softness, the company sustained market leadership, maintaining a 41.4% global toothpaste market share.
- Net sales in Q3 2026 reached $5,369 million (+4.6% YoY) with organic sales growth of 3.6%, while GAAP net income attributable to the company rose to $751 million ($0.94 diluted EPS; $0.97 non-GAAP diluted EPS).
- Operating cash flow reached $2,913 million for the first nine months of 2026 compared to $2,745 million in 2025, funding $1,308 million in dividends and $927 million in treasury share repurchases.
- Cumulative pre-tax restructuring charges under the Strategic Growth and Productivity Program reached $346 million as of September 30, 2026, out of an estimated total of $350 to $550 million expected by December 31, 2028.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Colgate-Palmolive (2026-10-30)
On October 30, 2026, Colgate-Palmolive Company furnished a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing the release of its financial results for the third quarter ended September 30, 2026. The earnings release itself was distributed via Exhibit 99 and incorporated by reference, with the filing signed by Chief Financial Officer Stanley J. Sutula III. Because the detailed financial tables and operational discussion were furnished via the accompanying press release exhibit rather than directly in the body of the 8-K, this document serves as the regulatory furnishing establishing the disclosure of Q3 2026 performance.
- Colgate-Palmolive furnished its Q3 earnings release for the quarterly period ended September 30, 2026, on October 30, 2026.
- The filing was furnished under Item 2.02 and signed on behalf of the registrant by Chief Financial Officer Stanley J. Sutula III.
- Detailed financial statements and commentary were provided via Exhibit 99 (Press release dated October 30, 2026) and incorporated by reference.
Kimberly-Clark
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-20)
On October 19, 2026, Kimberly-Clark Corporation priced a private offering under Rule 144A and Regulation S of senior unsecured notes across five tranches totaling $4.9 billion in aggregate principal amount. The tranches mature between 2028 and 2036, carrying fixed interest coupons ranging from 5.100% to 5.800%. The offering is scheduled to close on or about October 29, 2026, subject to customary closing conditions. The capital raise directly funds the cash consideration, fees, and expenses for Kimberly-Clark's pending acquisition of Kenvue Inc., slated for completion in Q4 2026. The notes feature a special mandatory redemption clause requiring redemption at 101% of principal plus accrued interest if the acquisition does not close by May 31, 2027 (or an agreed outside date) or is abandoned. This transaction solidifies the debt financing structure essential for closing the mega-cap consumer health transaction.
- Kimberly-Clark priced $4.9 billion in senior unsecured notes across five tranches: $750M at 5.100% due 2028, $1.0B at 5.300% due 2029, $1.25B at 5.450% due 2031, $750M at 5.650% due 2034, and $1.15B at 5.800% due 2036.
- Proceeds will finance the cash consideration and expenses for the pending acquisition of Kenvue Inc., expected to close in Q4 2026.
- The notes carry a 101% special mandatory redemption provision if the Kenvue acquisition is terminated or not consummated by May 31, 2027 (or a later agreed outside date).
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-13)
Kimberly-Clark Corporation announced the early tender results of its private exchange offers and consent solicitations to exchange up to $7.0 billion aggregate principal amount of notes issued by Kenvue Inc. for new Kimberly-Clark notes and cash. As of the October 9, 2026 early participation date, Kimberly-Clark secured the requisite consents across all series of Kenvue Notes to adopt proposed indenture amendments, which eliminate substantially all restrictive covenants, SEC reporting requirements, and merger/asset-transfer restrictions on Kenvue. The settlement remains conditioned upon the closing of Kimberly-Clark's pending acquisition of Kenvue, anticipated in the fourth quarter of 2026.
- Requisite consents were received by October 9, 2026, across all series of Kenvue Notes to execute supplemental indentures eliminating restrictive covenants and reporting obligations.
- The transaction offers to exchange up to $7.0 billion aggregate principal amount of Kenvue notes for new Kimberly-Clark debt securities plus cash consideration.
- Settlement is scheduled to coincide with the closing of Kimberly-Clark's acquisition of Kenvue, expected in Q4 2026, with settlement not anticipated before November 2, 2026.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-15)
Kimberly-Clark Corporation issued a Current Report on Form 8-K to furnish preliminary estimated financial results for the third quarter ended September 30, 2026, while reaffirming its full-year 2026 outlook. The company reported estimated net sales of $4,134 million, reflecting a 0.4% reported net sales decline and a 1.3% contraction in organic sales growth. Operating profit is estimated at $516 million compared to $621 million in Q3 2025, while adjusted operating profit stood relatively stable at $677 million versus $683 million in the prior year. Diluted earnings per share attributable to Kimberly-Clark jumped to $5.37, driven primarily by a $4.33 per share transaction gain on the International Family Care and Professional (IFP) transaction with Suzano S.A., though adjusted EPS attributable to Kimberly-Clark decreased to $1.70 from $1.82. The company incurred $106 million ($0.27 per share) in transaction and advisory costs related to its pending acquisition of Kenvue Inc., along with $55 million in charges under its 2024 Transformation Initiative. Cash and cash equivalents surged to $1,874 million as of September 30, 2026.
- Q3 2026 estimated net sales reached $4,134 million, down 0.4% year-over-year, with organic sales contracting by 1.3%.
- Diluted EPS attributable to Kimberly-Clark rose to $5.37, substantially boosted by an IFP transaction gain of $4.33 per share, while adjusted EPS attributable to the company declined from $1.82 to $1.70.
- The company recognized $106 million ($0.27 per share) in advisory and legal costs associated with the pending Kenvue Inc. acquisition and $55 million ($0.13 per share) under the 2024 Transformation Initiative.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Colgate-Palmolive and Kimberly-Clark share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks